Interestingly, a recent study showed that R-2-HG exposure in vitro reduced the HLA-DP expression on antigen-presenting cells and leukemic blasts, resulting in significantly impaired HLA-DP-mediated specific lysis of IDH-mutant AML blasts by TCR-engineered T cells (129). This evidence concerns the gene IDH2 and acute myeloid leukemia.